Literature DB >> 23855686

Cell therapy trials for lung diseases: progress and cautions.

Daniel J Weiss, Luis A Ortiz.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23855686      PMCID: PMC3778760          DOI: 10.1164/rccm.201302-0351ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  20 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Cell therapy for fibrotic interstitial pulmonary disease: experimental study.

Authors:  Rosa M Cabral; Érika Branco; Márcia Dos S Rizzo; Guilherme J Ferreira; Guilherme B Gregores; Vivian Y Samoto; Angelo J Stopiglia; Paulo C Maiorka; Emerson T Fioretto; Vera L Capelozzi; João B Borges; Susimeire Gomes; Marcelo A Beraldo; Carlos R R Carvalho; Maria A Miglino
Journal:  Microsc Res Tech       Date:  2011-01-04       Impact factor: 2.769

Review 3.  Idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Annie Pardo; Moisés Selman
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

4.  Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

Authors:  L von Bahr; I Batsis; G Moll; M Hägg; A Szakos; B Sundberg; M Uzunel; O Ringden; K Le Blanc
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

5.  An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.

Authors:  Gustavo Matute-Bello; Gregory Downey; Bethany B Moore; Steve D Groshong; Michael A Matthay; Arthur S Slutsky; Wolfgang M Kuebler
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05       Impact factor: 6.914

6.  Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis.

Authors:  Michael W Epperly; Hongliang Guo; Joan E Gretton; Joel S Greenberger
Journal:  Am J Respir Cell Mol Biol       Date:  2003-03-20       Impact factor: 6.914

7.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

8.  Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung.

Authors:  Xi Yan; Yanning Liu; Qin Han; Mingyue Jia; Lianming Liao; Maili Qi; Robert Chunhua Zhao
Journal:  Exp Hematol       Date:  2007-07-16       Impact factor: 3.084

Review 9.  Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.

Authors:  Rebecca L Toonkel; Joshua M Hare; Michael A Matthay; Marilyn K Glassberg
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  17 in total

Review 1.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

2.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

3.  Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.

Authors:  Adeline Blandinières; Thomas Gille; Jérémy Sadoine; Ivan Bièche; Lofti Slimani; Blandine Dizier; Pascale Gaussem; Catherine Chaussain; Carole Planes; Peter Dorfmüller; Dominique Israël-Biet; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 4.  Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.

Authors:  Marek Barczyk; Matthias Schmidt; Sabrina Mattoli
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

5.  Best of Milan 2017-repair of the emphysematous lung: mesenchymal stromal cell and matrix.

Authors:  Francesca Polverino
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 6.  Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.

Authors:  Daniel J Weiss
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

7.  Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice.

Authors:  Chava Rosen; Elias Shezen; Anna Aronovich; Yael Zlotnikov Klionsky; Yasmin Yaakov; Miri Assayag; Inbal Eti Biton; Orna Tal; Guy Shakhar; Herzel Ben-Hur; David Shneider; Zvi Vaknin; Oscar Sadan; Shmuel Evron; Enrique Freud; David Shoseyov; Michael Wilschanski; Neville Berkman; Willem E Fibbe; David Hagin; Carmit Hillel-Karniel; Irit Milman Krentsis; Esther Bachar-Lustig; Yair Reisner
Journal:  Nat Med       Date:  2015-07-13       Impact factor: 53.440

8.  Modified mesenchymal stem cells using miRNA transduction alter lung injury in a bleomycin model.

Authors:  Luai Huleihel; Jacobo Sellares; Nayra Cardenes; Diana Álvarez; Rosa Faner; Koji Sakamoto; Guoying Yu; Maria G Kapetanaki; Naftali Kaminski; Mauricio Rojas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-06       Impact factor: 5.464

Review 9.  Lung regeneration: mechanisms, applications and emerging stem cell populations.

Authors:  Darrell N Kotton; Edward E Morrisey
Journal:  Nat Med       Date:  2014-08       Impact factor: 53.440

Review 10.  Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution.

Authors:  Anna Valeria Samarelli; Roberto Tonelli; Irene Heijink; Aina Martin Medina; Alessandro Marchioni; Giulia Bruzzi; Ivana Castaniere; Dario Andrisani; Filippo Gozzi; Linda Manicardi; Antonio Moretti; Stefania Cerri; Riccardo Fantini; Luca Tabbì; Chiara Nani; Ilenia Mastrolia; Daniel J Weiss; Massimo Dominici; Enrico Clini
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.